Defence And Security Tenders

Jointly Sponsored Ruth L. Kirschstein National Research Service Award Institutional Predoctoral Training Program in the Neurosciences (T32 Clinical Trial not Allowed)

Nida Avant-Garde Program for Hiv and Substance Use Disorder Research (Dp1 Clinical Trial Optional)

Fireline and Mobile Equipment Opportunities

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Substance Abrocitinib, Atc D11ah08 for the Period May 1St, 2023 - April 30Th, 2025

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Ingredient Peginterferon Beta-1A, Atc L03ab13 for the Period May 1St, 2023 - April 30Th, 2025

Open House Drug Rebate Contracts Formoterol and Aclidinium Bromide, Atc R03al05

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Ingredient Finished Drug Smofkabiven, Atc B05ba10 for the Period May 1St, 2023 - April 30Th, 2025

Open House Discount Drug Contracts for Dexamethasone and Gentamicin, Atc S01ca21

Dynamic Purchasing System - Metals Revised

Conclusion of a Non-Exclusive Discount Agreement in Accordance with § 130A Paragraph 8 Sgb V for the Active Substance Interferon Beta-1A (Excl. for Intramuscular Injection), Atc L03ab07 for the Period May 1St, 2023 - April 30Th, 2025